|Articles|September 1, 2011
- Pharmaceutical Executive-09-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - September 2011
From Many, One
Advertisement
Articles in this issue
about 14 years ago
Pharm Exec's 10th Annual Industry Auditabout 14 years ago
Pharma and Social Media: Ready to Make Nice?about 14 years ago
The Power of Product Development Partnershipabout 14 years ago
Front and Center in the Fight against TBabout 14 years ago
How to Recruit 70,000 People in One Yearabout 14 years ago
Innovating Around Innovationabout 14 years ago
India: Good Endings, Good Beginnings!about 14 years ago
Two Million Man Hoursabout 14 years ago
Rebates and Reformabout 14 years ago
Should the US Gamble with Risk Sharing?Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Excellergy Announces Launch with $70 Million Series A Funding Aiming to Advance Pipeline of Trifunctional Effector Cell Response Inhibitors
2
How are the Drug Pricing Negotiations Impacting Pharma's Relationship with DC?
3
Pharma Companies Shift Towards Direct-To-Consumer Sales in US Amidst Tariff and Pricing Turmoil
4
Policy Whiplash in Pharma: Navigating Volatility with Strategic Clarity
5
